Importantly, the KE-37 line is part of a group of human T-ALL cell lines in which the growth is not inhibited by GSI treatment, probably due to a lack in the expression of the PTEN gene, although GSI is effective in blocking Notch1 activation [(43) and references therein]. The gene discussed is PTEN; the disease is acute lymphoblastic leukemia.